Dr Lorch (second from left) and Dr Täubel (third from left) visiting business partners in Japan

Our Managing Director Dr Jörg Täubel and Medical Director Dr Ulrike Lorch recently travelled to Japan to meet with business partners and learn more about the Japanese way of doing business.Nemawashi is a Japanese business process which assures a consensus and harmony between business partners. Nemawashi allows both parties to save valuable time before important meetings because both sides are able to adjust opinions and positions beforehand.

Dr Täubel (second from left) and Dr Lorch (third from left) visiting business partners in Japan

Dr Täubel and Dr Lorch gained first hand experience of Nemawashi during the week-long trip, during which time they met with a range of policy makers, media and business partners to gain further insights into the Japanese CRO and SMO markets.“The trip was a huge success” said Dr Lorch. “Not only did we hold very positive meetings with stakeholders, we also discovered a new and exciting way of life. I have started learning Japanese to help develop relations with our partners in future!”

Latest news

Red4Research Blog – Alan’s Story

June 24, 2025
#Red4Research is a global initiative that recognises the essential role of clinical research in improving treatment, outcomes, and the future of medicine.
Read more

Richmond Appoints Lisa Campbell as Director of Regulatory Strategy

April 23, 2025
Richmond Pharmacology is pleased to announce the appointment of Lisa Campbell as Director of Regulatory Strategy
Read more

Events

HFA 2025

17–20 May 2025
Richmond Pharmacology will participate in HFA 2025 in Belgrade from 17–20 May, focusing on heart failure research, clinical trials, and scientific collaboration.
View event